The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Loxo
A pediatric phase 1 study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family.
 
Ramamoorthy Nagasubramanian
No Relationships to Disclose
 
Steven G. DuBois
Honoraria - Loxo
Research Funding - Merck (Inst); Millennium (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Loxo
 
Theodore Willis Laetsch
No Relationships to Disclose
 
Leo Mascarenhas
No Relationships to Disclose
 
Steven Smith
Consulting or Advisory Role - Loxo
 
Mark Reynolds
Consulting or Advisory Role - Loxo
 
Scott Cruickshank
Consulting or Advisory Role - Loxo
 
Lia Donahue
Employment - Loxo
Stock and Other Ownership Interests - Loxo
 
Alberto S. Pappo
Consulting or Advisory Role - ZIOPHARM Oncology
 
Michael Craig Cox
Employment - Bayer; Loxo
Stock and Other Ownership Interests - Loxo